The
antiestrogens MER-25,
CI-628, and
nafoxidine inhibit the uptake of [3H]-
estradiol in whole homogenates and isolated cell nuclei tissues and the pituitary, and inhibit
estradiol-induced female sexual behavior. The
antiestrogens were injected intraperitoneally 2 h prior to an
intravenous injection of [3H]
estradiol, and the animals were killed 2 h after the
estradiol.
CI-628 reduces radioactivity in whole homogenates and isolated cell nuclei of cerebral cortex, hypothalamus, preoptic area -septum and pituitary.
Nafoxidine reduces uptake in cell nuclei of the hypothalamus, preoptic area-septum and pituitary. In this paradigm,
MER-25 inhibited uptake only in the pituitary. In the analogous behavioral experiments, with
antiestrogens injected 2 h prior to an
intravenous injection of unesterified
estradiol,
CI-628 and
nafoxidine totally inhibited
lordosis responding.
MER-25 shows no inhibition of behavior in this paradigm. However, when
MER-25 is injected 12 h prior to the
estradiol, it inhibits retention of [3H]
estradiol at 2 h in brain and pituitary cell nuclei, and
lordosis responding is also inhibited. Additionally, the
antiestrogens can apparently displace previously bound [3H]estrdiol. When the
antiestrogens are injected 2 h prior to an injection of [3H]
estradiol,
MER-25,
CI-628 and
nafoxidine all show greater inhibition of nuclear
estradiol retention at 12 h after the [3H]
estradiol injection than 2 h. Analogously, when
CI-628 is injected 2 h after an
intravenous injection of [3H]
estradiol, it displaces most of the radioactivity present in hypothalamic-preoptic area nuclei at 12 h after the
estradiol injection. These results indicate that
antiestrogens can prevent or reverse the nuclear concentration of
estradiol in brain cells and are consistent with a role of the cell nucleus in the induction of estrous behavior by
estradiol.